{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T23:13:39Z","timestamp":1790723619660,"version":"4.1.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T00:00:00Z","timestamp":1718841600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hazardous Materials"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.jhazmat.2024.134998","type":"journal-article","created":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T17:36:38Z","timestamp":1718991398000},"page":"134998","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Pharmaceutical emissions on the example of the Baltic Sea catchment: comparing measurements with multi-tier predictive models"],"prefix":"10.1016","volume":"476","author":[{"given":"Vaidotas","family":"Kisielius","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauri","family":"\u00c4yst\u00f6","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terhi","family":"Lehtinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suman","family":"Kharel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Stapf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"Zhiteneva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noora","family":"Perkola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Bester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhazmat.2024.134998_bib1","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/etc.3339","article-title":"Pharmaceuticals in the environment\u2014Global occurrences and perspectives","volume":"35","author":"aus der Beek","year":"2016","journal-title":"Environ Toxicol Chem"},{"key":"10.1016\/j.jhazmat.2024.134998_bib2","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1289\/ehp.99107s6907","article-title":"Pharmaceuticals and personal care products in the environment: agents of subtle change?","volume":"107","author":"Daughton","year":"1999","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.jhazmat.2024.134998_bib3","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.watres.2018.03.056","article-title":"Analysis of endocrine activity in drinking water, surface water and treated wastewater from six countries","volume":"139","author":"Leusch","year":"2018","journal-title":"Water Res"},{"key":"10.1016\/j.jhazmat.2024.134998_bib4","doi-asserted-by":"crossref","first-page":"10308","DOI":"10.1021\/acs.est.6b03338","article-title":"Mind the gap: persistent and mobile organic compounds\u2014water contaminants that slip through","volume":"50","author":"Reemtsma","year":"2016","journal-title":"Environ Sci Technol"},{"issue":"2","key":"10.1016\/j.jhazmat.2024.134998_bib5","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1080\/02508060.2021.1889867","article-title":"A source-to-sea approach to emerging pollutants in freshwater and oceans: pharmaceuticals in the Baltic Sea region","volume":"46","author":"Zandaryaa","year":"2021","journal-title":"Water Int"},{"issue":"1","key":"10.1016\/j.jhazmat.2024.134998_bib6","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.aquatox.2005.07.006","article-title":"Water-borne diclofenac affects kidney and gill integrity and selected immune parameters in brown trout (Salmo trutta f. fario)","volume":"75","author":"Hoeger","year":"2005","journal-title":"Aquat Toxicol"},{"key":"10.1016\/j.jhazmat.2024.134998_bib7","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.scitotenv.2004.02.004","article-title":"Leaching behaviour of pharmaceuticals in soil-testing-systems: a part of an environmental risk assessment for groundwater protection","volume":"328","author":"Oppel","year":"2004","journal-title":"Sci Total Environ"},{"key":"10.1016\/j.jhazmat.2024.134998_bib8","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.aquatox.2010.08.010","article-title":"Triclosan persistence through wastewater treatment plants and its potential toxic effects on river biofilms","volume":"100","author":"Ricart","year":"2010","journal-title":"Aquat Toxicol"},{"key":"10.1016\/j.jhazmat.2024.134998_bib9","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.scitotenv.2017.07.042","article-title":"Impact of the NSAID diclofenac on survival, development, behaviour and health of embryonic and juvenile stages of brown trout, Salmo trutta f. fario","volume":"607-608","author":"Schwarz","year":"2017","journal-title":"Sci Total Environ"},{"key":"10.1016\/j.jhazmat.2024.134998_bib10","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/wat2.1006","article-title":"Pharmaceuticals in surface waters: sources, behavior, ecological risk, and possible solutions. Case study of Lake Geneva, Switzerland","volume":"1","author":"Chevre","year":"2014","journal-title":"WIREs Water"},{"issue":"8","key":"10.1016\/j.jhazmat.2024.134998_bib11","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1016\/j.jenvman.2009.01.023","article-title":"The presence of pharmaceuticals in the environment due to human use--present knowledge and future challenges","volume":"90","author":"Kummerer","year":"2009","journal-title":"J Environ Manag"},{"key":"10.1016\/j.jhazmat.2024.134998_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fenvs.2022.1077974","article-title":"Minimizing the environmental impact of unused pharmaceuticals: review focused on prevention","volume":"10","author":"Paut Kusturica","year":"2022","journal-title":"Front Environ Sci"},{"key":"10.1016\/j.jhazmat.2024.134998_bib13","series-title":"Human Pharmaceuticals, Hormones and Fragrances. The Challenge of Micropollutants in Urban Water Management.","author":"Ternes","year":"2006"},{"key":"10.1016\/j.jhazmat.2024.134998_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1098\/rstb.2013.0586","article-title":"Potential ecological footprints of active pharmaceutical ingredients: An examination of risk factors in low-, middle- and high-income countries","volume":"369","author":"Kookana","year":"2014","journal-title":"Philos Trans R Soc B"},{"issue":"1-2","key":"10.1016\/j.jhazmat.2024.134998_bib15","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.watres.2007.07.012","article-title":"Determination of the solid-water distribution coefficient (Kd) for pharmaceuticals, estrogens and musk fragrances in digested sludge","volume":"42","author":"Carballa","year":"2008","journal-title":"Water Res"},{"key":"10.1016\/j.jhazmat.2024.134998_bib16","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.microc.2013.04.014","article-title":"Occurrence, transportation, monitoring and treatment of emerging micro-pollutants in waste water \u2014 a review from global views","volume":"110","author":"Jiang","year":"2013","journal-title":"Microchem J"},{"issue":"8","key":"10.1016\/j.jhazmat.2024.134998_bib17","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1016\/j.watres.2006.02.014","article-title":"Biological degradation of pharmaceuticals in municipal wastewater treatment: proposing a classification scheme","volume":"40","author":"Joss","year":"2006","journal-title":"Water Res"},{"key":"10.1016\/j.jhazmat.2024.134998_bib18","doi-asserted-by":"crossref","first-page":"4141","DOI":"10.1016\/j.scitotenv.2010.08.061","article-title":"Combination of advanced oxidation processes and biological treatments for wastewater decontamination\u2014a review","volume":"409","author":"Oller","year":"2011","journal-title":"Sci Total Environ"},{"issue":"3","key":"10.1016\/j.jhazmat.2024.134998_bib19","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.watres.2008.11.043","article-title":"Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment","volume":"43","author":"Radjenovic","year":"2009","journal-title":"Water Res"},{"key":"10.1016\/j.jhazmat.2024.134998_bib20","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.chemosphere.2019.06.041","article-title":"Mass loads, source apportionment, and risk estimation of organic micropollutants from hospital and municipal wastewater in recipient catchments","volume":"234","author":"S\u00f6reng\u00e5rd","year":"2019","journal-title":"Chemosphere"},{"key":"10.1016\/j.jhazmat.2024.134998_bib21","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.marpolbul.2019.07.014","article-title":"Assessment of input of organic micropollutants and microplastics into the Baltic Sea by urban waters","volume":"148","author":"Bollmann","year":"2019","journal-title":"Mar Pollut Bull"},{"key":"10.1016\/j.jhazmat.2024.134998_bib22","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.watres.2008.10.039","article-title":"Persistence and partitioning of eight selected pharmaceuticals in the aquatic environment: laboratory photolysis, biodegradation, and sorption experiments","volume":"43","author":"Yamamoto","year":"2009","journal-title":"Water Res"},{"key":"10.1016\/j.jhazmat.2024.134998_bib23","unstructured":"HELCOM, 2013. Approaches and methods for eutrophication target setting in the Baltic Sea region. Baltic Sea Environment Proceedings 133. Helsinki. https:\/\/helcom.fi\/wp-content\/uploads\/2019\/08\/Eutorophication-targets_BSEP133.pdf [accessed 4 May, 2023]."},{"issue":"5","key":"10.1016\/j.jhazmat.2024.134998_bib24","doi-asserted-by":"crossref","first-page":"eaar8195","DOI":"10.1126\/sciadv.aar8195","article-title":"The Baltic Sea as a time machine for the future coastal ocean","volume":"4","author":"Reusch","year":"2018","journal-title":"Sci Adv"},{"key":"10.1016\/j.jhazmat.2024.134998_bib25","unstructured":"European Commission, 2022a. Proposal for a directive of the European Parliament and of the Council concerning urban wastewater treatment. Brussels, 26.10.2022. COM(2022) 541 final. 2022\/0345 (COD)."},{"key":"10.1016\/j.jhazmat.2024.134998_bib26","unstructured":"European Commission, 2022b. Proposal for a directive of the European Parliament and of the Council amending Directive 2000\/60\/EC establishing a framework for Community action in the field of water policy, Directive 2006\/118\/EC on the protection of groundwater against pollution and deterioration and Directive 2008\/105\/EC on environmental quality standards in the field of water policy. Brussels, 26.10.2022. COM(2022) 540 final. 2022\/0344 (COD)."},{"key":"10.1016\/j.jhazmat.2024.134998_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2023.146644","article-title":"Process design for removal of pharmaceuticals in wastewater treatment plants based on Predicted No Effect Concentration (PNEC)","author":"Kisielius","year":"2023","journal-title":"Chem Eng J"},{"key":"10.1016\/j.jhazmat.2024.134998_bib28","unstructured":"The Danish Health Data Authority, 2021. Register of Medicinal Products Statistics. Available from: https:\/\/medstat.dk\/. [Accessed 30 April 2023]."},{"key":"10.1016\/j.jhazmat.2024.134998_bib29","unstructured":"Official Statistics of Finland, 2021. Population structure. ISSN=1797\u20135395. http:\/\/www.stat.fi\/til\/vaerak\/2020\/vaerak_2020_2021\u201303-31_tie_001_en.html. [Accessed 2023\u201304-30]."},{"key":"10.1016\/j.jhazmat.2024.134998_bib30","unstructured":"Republic of Estonia Agency of Medicines, 2023. Statistics on Medicines. \u3008https:\/\/ravimiamet.ee\/en\/statistics\/statistics-medicines\u3009. [Accessed 2024\u201301-31]."},{"key":"10.1016\/j.jhazmat.2024.134998_bib31","unstructured":"Socialstyrelsen, 2022. National Prescribed Drug Register. https:\/\/www.socialstyrelsen.se\/en\/statistics-and-data\/registers\/national-prescribed-drug-register\/. [Accessed 2024\u201301-31]."},{"key":"10.1016\/j.jhazmat.2024.134998_bib32","unstructured":"State Medicines Control Agency of Lithuania, 2023. Available from: https:\/\/vvkt.lrv.lt\/lt\/svarbi-informacija\/parduotu-vaistiniu-preparatu-pakuociu-kiekiai-ir-ju-atsargos\/parduotu-vaistinems-ir-aspi-vaistiniu-preparatu-pakuociu-kiekis\/."},{"key":"10.1016\/j.jhazmat.2024.134998_bib33","unstructured":"Finnish Medicines Agency, 2023. www.fimea.fi."},{"key":"10.1016\/j.jhazmat.2024.134998_bib34","unstructured":"Sweetman, S. (Ed.), 2020. Martindale: The Complete Drug Reference. London: The Royal Pharmaceutical Society of Great Britain. Ed. 40. Michigan, USA."},{"key":"10.1016\/j.jhazmat.2024.134998_bib35","unstructured":"European Medicines Agency, 2006. Committee for Medicinal Products for Human Use (CHMP). Guideline on the environmental risk assessment of medicinal products for human use. London. Doc. Ref. EMEA\/CHMP\/SWP\/4447\/00 corr 2. https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/guideline-environmental-risk-assessment-medicinal-products-human-use-first-version_en.pdf [Accessed 4 May 2023]."},{"key":"10.1016\/j.jhazmat.2024.134998_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2020.105690","article-title":"Sale-based estimation of pharmaceutical concentrations and associated environmental risk in the Japanese wastewater system","volume":"139","author":"He","year":"2020","journal-title":"Environ Int"},{"key":"10.1016\/j.jhazmat.2024.134998_bib37","doi-asserted-by":"crossref","first-page":"10966","DOI":"10.1007\/s11356-018-1343-5","article-title":"Predicted environmental concentration and fate of the top 10 most dispensed Australian prescription pharmaceuticals","volume":"25","author":"Ong","year":"2018","journal-title":"Environ Sci Pollut Res"},{"key":"10.1016\/j.jhazmat.2024.134998_bib38","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.scitotenv.2013.10.026","article-title":"Comparison of measured and predicted concentrations of selected pharmaceuticals in wastewater and surface water: a case study of a catchment area in the Po Valley (Italy)","author":"Verlicchi","year":"2014","journal-title":"Sci Total Environ 470\u2013471"},{"key":"10.1016\/j.jhazmat.2024.134998_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2023.167440","article-title":"Ecotoxicological mixture risk assessment of 35 pharmaceuticals in wastewater effluents following post-treatment with ozone and\/or granulated activated carbon","volume":"906","author":"Spilsbury","year":"2024","journal-title":"Sci Total Environ"},{"issue":"17","key":"10.1016\/j.jhazmat.2024.134998_bib40","doi-asserted-by":"crossref","first-page":"6475","DOI":"10.1016\/j.watres.2013.08.024","article-title":"EU-wide monitoring survey on emerging polar organic contaminants in wastewater treatment plant effluents","volume":"47","author":"Loos","year":"2013","journal-title":"Water Res"},{"key":"10.1016\/j.jhazmat.2024.134998_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2020.105733","article-title":"Antibiotic residues in final effluents of European wastewater treatment plants and their impact on the aquatic environment","volume":"140","author":"Rodriguez-Mozaz","year":"2020","journal-title":"Environ Int"},{"key":"10.1016\/j.jhazmat.2024.134998_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2023.115149","article-title":"Hospitals and households as primary emission sources for risk-posing pharmaceuticals in municipal wastewater","volume":"262","author":"\u00c4yst\u00f6","year":"2023","journal-title":"Ecotoxicol Environ Saf"},{"key":"10.1016\/j.jhazmat.2024.134998_bib43","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.talanta.2012.08.032","article-title":"Multi-residue method for trace level determination of pharmaceuticals in environmental samples using liquid chromatography coupled to triple quadrupole mass spectrometry","volume":"100","author":"Grabic","year":"2012","journal-title":"Talanta"},{"key":"10.1016\/j.jhazmat.2024.134998_bib44","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.envpol.2016.10.106","article-title":"Investigation and risk evaluation of the occurrence of carbamazepine, oxcarbazepine, their human metabolites and transformation products in the urban water cycle","volume":"225","author":"Brezina","year":"2017","journal-title":"Environ Pollut"},{"key":"10.1016\/j.jhazmat.2024.134998_bib45","article-title":"New hazardous substances in Finnish wastewater treatment plants","volume":"70","author":"Vieno","year":"2021","journal-title":"Vesilaitosyhdistyksen Monistesar nro"},{"key":"10.1016\/j.jhazmat.2024.134998_bib46","doi-asserted-by":"crossref","first-page":"611","DOI":"10.3109\/00498257909042328","article-title":"Biotransformation of diclofenac sodium (Voltaren) in animals and in man. II. Quantitative determination of the unchanged drug and principal phenolic metabolites, in urine and bile","volume":"9","author":"Stierlin","year":"1979","journal-title":"Xenobiotica"},{"key":"10.1016\/j.jhazmat.2024.134998_bib47","doi-asserted-by":"crossref","first-page":"184","DOI":"10.2165\/00003088-199733030-00003","article-title":"Clinical pharmacokinetics of diclofenac: therapeutic insights and pitfalls","volume":"33","author":"Davies","year":"1997","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jhazmat.2024.134998_bib48","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1023\/A:1011911302005","article-title":"In vivo bioavailability and metabolism of topical dicofenac lotion in human volunteers","volume":"15","author":"Hui","year":"1998","journal-title":"Pharm Res"},{"key":"10.1016\/j.jhazmat.2024.134998_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2020.141624","article-title":"The importance of over-the-counter-sales and product format in the environmental exposure assessment of active pharmaceutical ingredients","volume":"752","author":"Austin","year":"2021","journal-title":"Sci Total Environ"},{"key":"10.1016\/j.jhazmat.2024.134998_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.watres.2022.118221","article-title":"Large-scale assessment of organic contaminant emissions from chemical and pharmaceutical manufacturing into Swiss surface waters","volume":"215","author":"Anliker","year":"2022","journal-title":"Water Res"},{"key":"10.1016\/j.jhazmat.2024.134998_bib51","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1007\/s10646-015-1548-z","article-title":"Degradation of PPCPs in activated sludge from different WWTPs in Denmark","volume":"24","author":"Chen","year":"2015","journal-title":"Ecotoxicology"},{"key":"10.1016\/j.jhazmat.2024.134998_bib52","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.watres.2016.03.009","article-title":"Tracing the limits of organic micropollutant removal in biological wastewater treatment","volume":"95","author":"Fal\u00e5s","year":"2016","journal-title":"Water Res"},{"issue":"2","key":"10.1016\/j.jhazmat.2024.134998_bib53","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.watres.2009.07.004","article-title":"Occurrence of emerging pollutants in urban wastewater and their removal through biological treatment followed by ozonation","volume":"44","author":"Rosal","year":"2010","journal-title":"Water Res"},{"key":"10.1016\/j.jhazmat.2024.134998_bib54","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.watres.2008.10.047","article-title":"The removal of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs during wastewater treatment and its impact on the quality of receiving waters","volume":"43","author":"Kasprzyk-Hordern","year":"2009","journal-title":"Water Res"},{"key":"10.1016\/j.jhazmat.2024.134998_bib55","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.envint.2014.03.021","article-title":"Fate of diclofenac in municipal wastewater treatment plant - a review","volume":"69","author":"Vieno","year":"2014","journal-title":"Environ Int"},{"key":"10.1016\/j.jhazmat.2024.134998_bib56","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.scitotenv.2013.01.007","article-title":"Hydroxyl radical induced degradation of ibuprofen","volume":"447","author":"Ill\u00e9s","year":"2013","journal-title":"Sci Total Environ"},{"key":"10.1016\/j.jhazmat.2024.134998_bib57","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.chemosphere.2014.03.132","article-title":"Seasonal changes in antibiotics, antidepressants\/psychiatric drugs, antihistamines and lipid regulators in a wastewater treatment plant","volume":"111","author":"Golovko","year":"2014","journal-title":"Chemosphere"},{"key":"10.1016\/j.jhazmat.2024.134998_bib58","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1021\/es991118m","article-title":"Occurrence and behavior of X-ray contrast media in sewage facilities and the aquatic environment","volume":"34","author":"Ternes","year":"2000","journal-title":"Environ Sci Technol"}],"container-title":["Journal of Hazardous Materials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304389424015772?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304389424015772?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T10:06:51Z","timestamp":1742033211000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304389424015772"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":58,"alternative-id":["S0304389424015772"],"URL":"https:\/\/doi.org\/10.1016\/j.jhazmat.2024.134998","relation":{},"ISSN":["0304-3894"],"issn-type":[{"value":"0304-3894","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmaceutical emissions on the example of the Baltic Sea catchment: comparing measurements with multi-tier predictive models","name":"articletitle","label":"Article Title"},{"value":"Journal of Hazardous Materials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhazmat.2024.134998","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"134998"}}